help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
The Oncologist, Vol. 13, No. 3, 232-238, March 2008; doi:10.1634/theoncologist.2007-0203
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan-Smutko, G.
Right arrow Articles by Ryan, P. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chan-Smutko, G.
Right arrow Articles by Ryan, P. D.

Clinical Genetics and Genetic Counseling

Professional Challenges in Cancer Genetic Testing: Who Is the Patient?

Gayun Chan-Smutko, Devanshi Patel, Kristen M. Shannon, Paula D. Ryan

Massachusetts General Hospital Cancer Center/Center for Cancer Risk Assessment, Boston, Massachusetts, USA

Key Words. Duty-to-warn • Genetic testing • Family dynamics • Patient confidentiality

Correspondence: Gayun Chan-Smutko, M.S., C.G.C., 55 Fruit Street, YAW9A, Boston, Massachusetts 02114, USA. Telephone: 617-726-0292; Fax: 617-726-9418; e-mail: gchansmutko{at}partners.org; web site: http://massgeneral.org/cancer/care/adult/risk/index.asp

Disclosure: No potential conflicts of interest were reported by the authors, planners, reviewers, or staff managers of this article.

In the genetic counseling setting, the health care provider can be challenged by opposing duties to members of the same family: protecting the privacy of the patient identified with a gene mutation and the ethical obligation to warn at-risk relatives. In a situation of nondisclosure between members of a family with a known disease-predisposing mutation, this type of dilemma can present in acute form for the provider who cares for different members of the family. This can hinder effective medical decision making. To minimize this effect, we recommend detailed pretest genetic counseling steps to empower the patient to communicate with their at-risk relatives their intent to pursue testing and willingness to share information. In addition, post-test counseling should reiterate the implications of a positive result for at-risk relatives and conclude with a written summary that patients can share with their family.






HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2008 by AlphaMed Press.